相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signal transducer and transcriptional activation 1 protects against pressure overload-induced cardiac hypertrophy
Changlin Zhen et al.
FASEB JOURNAL (2021)
Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation
Weipeng Ge et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Mechanisms for the transition from physiological to pathological cardiac hypertrophy
Christopher J. Oldfield et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2020)
Hypertension and Heart Failure Prevention, Targets, and Treatment
Katherine E. Di Palo et al.
HEART FAILURE CLINICS (2020)
Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes
Fotios G. Pitoulis et al.
FRONTIERS IN PHYSIOLOGY (2020)
NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
Xin Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
Wei Yu et al.
ESC HEART FAILURE (2020)
mAKAPβ signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling
Kimberly Dodge-Kafka et al.
CELLULAR SIGNALLING (2019)
Programmed necrosis in heart disease: Molecular mechanisms and clinical implications
Hong Zhu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
The Transition From Hypertension to Heart Failure
Franz H. Messerli et al.
JACC-Heart Failure (2017)
Molecular switches under TGF signalling during progression from cardiac hypertrophy to heart failure
J. Heger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
Juan Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
分享论文
